CN1091611C - Monosaccharidase analgesic oral liquor - Google Patents
Monosaccharidase analgesic oral liquor Download PDFInfo
- Publication number
- CN1091611C CN1091611C CN99121059A CN99121059A CN1091611C CN 1091611 C CN1091611 C CN 1091611C CN 99121059 A CN99121059 A CN 99121059A CN 99121059 A CN99121059 A CN 99121059A CN 1091611 C CN1091611 C CN 1091611C
- Authority
- CN
- China
- Prior art keywords
- gram
- grams
- monosaccharidase
- herba
- oral liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a monosaccharidase pain relieving oral liquid which is prepared from various Chinese herbal medicines containing monosaccharidase and wine, wherein: 150 to 1800 grams of fresh cherry, 100 to 300 grams of barbed skullcap herb, 15 to 200 grams of oldenlandia diffusa, 0.5 to 4.5 grams of small centipeda herb, 10 to 100 grams of notoginseng, 6 to 40 grams of ginkgo leaf, 10 to 20 grams of hairyvein agrimonia herd, 10 to 50 grams of barbary wolfberry fruit and 3000 milliliters of wine. The oral liquid has the advantages of obvious effect and obvious pain relieving effect, effective rate reaches 100%, and the oral liquid is suitable for treating various cancers and various pain symptoms. All medicines are natural plants which have the advantage of no toxic or side effect and can perform the functions of regulating in two ways, reducing blood sugar, reducing blood lipid and reducing blood pressure besides the pain relieving function. In addition, the oral liquid has the advantages of wide raw material source, simple processing and low cost.
Description
The present invention relates to a kind of analgesic drug product, be meant especially by multiple to contain the analgesic oral liquor that monosaccharide enzyme Chinese herbal medicine is made.
Because the pain that various diseases cause has been brought great misery to the patient.The medicine of present treatment pain is still based on Western medicine, but nearly all analgesic drug product all has bigger side effect, and is bigger to gastrointestinal stimulation, and the patient uses back addiction easily.
The object of the present invention is to provide a kind of analgesic oral liquor of making by the multiple Chinese herbal medicine that contains the monosaccharide enzyme, analgesic effect is obvious, human body is had no side effect, and can also play effects such as blood sugar lowering, blood fat reducing, blood pressure lowering, the patient who is suitable for various body constitution takes.
Monosaccharidase analgesic oral liquor of the present invention is formulated with multiple Chinese herbal medicine and the Chinese liquor that contains the monosaccharide enzyme, and various compositions and proportioning are:
Bright Fructus Pruni pseudocerasi 150-1800 gram Herba Scutellariae Barbatae 100-300 gram
Herba Hedyotidis Diffusae 15-200 gram Herba Centipedae 0.5-4.5 gram
Radix Notoginseng 10-100 gram Folium Ginkgo 6-40 gram
Herba Agrimoniae 10-20 gram Fructus Lycii 10-50 gram
3000 milliliters of Chinese liquor
Monosaccharidase analgesic oral liquor of the present invention obtains through following processing method:
Earlier each Chinese herbal medicine is screened, cleans, cross 60 mesh sieves and pulverize, the Chinese herbal medicine after pulverizing is joined in the Chinese liquor by said ratio, soaked 30-40 days, remove by filter medicinal residues, finished product is made in the medicinal liquid bottling.
This oral liquid is taken 20ml through 715 routine all kinds of cancers and all kinds of pain patients clinical observation at every turn, and 3-30 minute takes effect, and curative effect can reach 100%.Relevant case is provided below.
Case 1: certain male's advanced esophageal cancer patient, 67 years old, pain unbearably, it is invalid to reach dolantin, take oral liquid 20ml of the present invention after, vomiting relieved the pain in 15 minutes in one hour, spirit takes a turn for the better.Painful promptly drink every day afterwards, by 3 hours once once by 8 hours, 16 hours are once.
Case 2: certain male's liver cancer patient, during 106 hospital's hospitalization, because of pain is injected 75% ethanol, invalid back beat dolantin still pain take this oral liquid and relieved the pain in 30 minutes unbearably,, then took once death after 1 year 07 months every 8 hours.
Case 3: certain male peasant, shift again after suffering from the pulmonary carcinoma excision, because of pain is taken the various medicines that relieve the pain, effect worse and worse, after change the clothes monosaccharidase analgesic oral liquor, every day three times, each 20ml.After 4 months, back pain disappears, weight increase.And through looking into, transfer portion is dwindled, and still adheres to taking this medicine so far, and is without any side effects.
Case 4: certain Ms, 76 years old, because of hypertension, a diabetes complicated left side have a pain in the leg bitterly, take monosaccharidase analgesic oral liquor after 2 months, blood glucose, blood pressure reduce, and pain disappears.
Case 5: certain Ms, 49 years old, suffer from uterus carcinoma, shift again after in March, 90 excision, every day pain endlessly.Take the multiple medicine DeGrain that relieves the pain, changed the clothes monosaccharidase analgesic oral liquor afterwards, every day 3 times, each 20ml, and add cancer therapy drug, not painful more so far.
In sum, compare with existing all kinds of analgesic drug products, the present invention has tangible advantage.Imbody is in the following areas:
1, take the back instant effect, 3-30 minute takes effect, relieving pain, and effective percentage 100%, applied widely is applicable to all kinds of cancers and all kinds of pain.
2, all medicines constitute by the natural plants that contains the monosaccharide enzyme, have no side effect, except that pain relieving, also can play dual regulation, blood sugar lowering, blood fat reducing, blood pressure lowering.
3, the raw material sources of monosaccharidase analgesic oral liquor of the present invention are extensive, processing and fabricating is simple, and are with low cost.
Embodiments of the invention are provided below.
Embodiment 1:
A kind of monosaccharidase analgesic oral liquor, this oral liquid is formulated with multiple Chinese herbal medicine and the Chinese liquor that contains the monosaccharide enzyme, and various compositions and proportioning are:
Bright Fructus Pruni pseudocerasi 150-300 gram Herba Scutellariae Barbatae 150-300 gram
Herba Hedyotidis Diffusae 15-100 gram Herba Centipedae 0.5-4.5 gram
Radix Notoginseng 10-50 gram Folium Ginkgo 20-40 gram
Herba Agrimoniae 10-20 gram Fructus Lycii 10-50 gram
3000 milliliters of Chinese liquor
Above-mentioned monosaccharidase analgesic oral liquor obtains through following processing method:
Earlier each Chinese herbal medicine is screened, cleans, cross 60 mesh sieves and pulverize, the Chinese herbal medicine after pulverizing is joined in the Chinese liquor by said ratio, soaked 30-40 days, remove by filter medicinal residues, finished product is made in the medicinal liquid bottling.
Embodiment 2:
A kind of monosaccharidase analgesic oral liquor, formulated with multiple Chinese herbal medicine and the Chinese liquor that contains the monosaccharide enzyme, various compositions and proportioning are:
Bright Fructus Pruni pseudocerasi 1000-1800 gram Herba Scutellariae Barbatae 100-200 gram
Herba Hedyotidis Diffusae 15-200 gram Herba Centipedae 0.5-4.5 gram
Radix Notoginseng 50-100 gram Folium Ginkgo 6-20 gram
Herba Agrimoniae 10-20 gram Fructus Lycii 10-50 gram
3000 milliliters of Chinese liquor
Above-mentioned monosaccharidase analgesic oral liquor obtains through following processing method:
Earlier each Chinese herbal medicine screened, clean, cross 60 mesh sieves and pulverize, the Chinese herbal medicine after pulverizing is joined in the Chinese liquor, soaked 30-40 days by said ratio, remove by filter medicinal residues, finished product is made in the medicinal liquid bottling.
Claims (2)
1, a kind of monosaccharidase analgesic oral liquor is characterized in that each material component and proportioning are:
Bright Fructus Pruni pseudocerasi 150-1800 gram Herba Scutellariae Barbatae 100-300 gram
Herba Hedyotidis Diffusae 15-200 gram Herba Centipedae 0.5-4.5 gram
Radix Notoginseng 10-100 gram Folium Ginkgo 6-40 gram
Herba Agrimoniae 10-20 gram Fructus Lycii 10-50 gram
3000 milliliters of Chinese liquor
2, a kind of preparation method of monosaccharidase analgesic oral liquor as claimed in claim 1 is characterized in that it may further comprise the steps:
Earlier each herbal raw material is screened, cleans, crossing 60 mesh sieves pulverizes, Chinese herbal medicine after pulverizing is joined in the Chinese liquor by following proportioning: 3000 milliliters of bright Fructus Pruni pseudocerasi 150-1800 grams, Herba Scutellariae Barbatae 100-300 gram, Herba Hedyotidis Diffusae 15-200 gram, Herba Centipedae 0.5-4.5 gram, Radix Notoginseng 10-100 gram, Folium Ginkgo 6-40 gram, Herba Agrimoniae 10-20 gram, Fructus Lycii 10-50 gram, Chinese liquor, soaked 30-40 days, remove by filter medicinal residues, finished product is made in the medicinal liquid bottling.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99121059A CN1091611C (en) | 1999-12-29 | 1999-12-29 | Monosaccharidase analgesic oral liquor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99121059A CN1091611C (en) | 1999-12-29 | 1999-12-29 | Monosaccharidase analgesic oral liquor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1262953A CN1262953A (en) | 2000-08-16 |
| CN1091611C true CN1091611C (en) | 2002-10-02 |
Family
ID=5281785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99121059A Expired - Fee Related CN1091611C (en) | 1999-12-29 | 1999-12-29 | Monosaccharidase analgesic oral liquor |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1091611C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105770180A (en) * | 2016-03-11 | 2016-07-20 | 张晓燕 | Internal and external pain alleviating tablet |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1060406A (en) * | 1991-06-29 | 1992-04-22 | 郭建秀 | The manufacture method of Chinese medicine antalgesic |
| CN1097611A (en) * | 1993-07-19 | 1995-01-25 | 艾培基 | Fast acting pain clearing medicine |
-
1999
- 1999-12-29 CN CN99121059A patent/CN1091611C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1060406A (en) * | 1991-06-29 | 1992-04-22 | 郭建秀 | The manufacture method of Chinese medicine antalgesic |
| CN1097611A (en) * | 1993-07-19 | 1995-01-25 | 艾培基 | Fast acting pain clearing medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1262953A (en) | 2000-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008533132A (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF DIABETIC OR DISEASE BLOOD REGULATION CONTAINING Ginsenoside | |
| CN1197481C (en) | Method for treatment of chronic venous insufficiencies using extract of red vine leaves | |
| CN1879802A (en) | Nutritious Chinese medicinal product for replenishing liver and kidney, resisting senility, decreasing blood fat, blood sugar and blood pressure and method for preparing same | |
| CN1091611C (en) | Monosaccharidase analgesic oral liquor | |
| CN101049438A (en) | Composition of Chinese traditional medicine for treating coronary heart disease | |
| CN107266599B (en) | Flammulina velutipes, extracting method and its application in terms of functional consitipation drug is treated in preparation | |
| CN1194724C (en) | Chinese medical preparation for treating coronary disease and angina pectoris and preparation thereof | |
| CN1309367C (en) | Preparation of Chinese traditional medicine for curing gallstone and preparation method | |
| CN1059117C (en) | Katsutoxin pill for tumor and preparing method thereof | |
| CN1745844A (en) | A kind of Chinese medicine composition for the treatment of chronic atrophic gastritis | |
| CN1081464C (en) | Chinese medicine for acute and chronic diarrhea, dysentery with purulent and bloody stools, as well as acute and chronic colitis | |
| CN102670922A (en) | Chinese medicine oral fluid with seeds of feather cockscomb for treating diarrhea and preparing method thereof | |
| CN112089783B (en) | Application of traditional Chinese medicine composition in preparation of medicine for preventing or/and treating obesity | |
| CN102406790A (en) | Traditional Chinese medicine capsule for treating hyperplasia of mammary glands and preparation method thereof | |
| CN1132613C (en) | Anti-impotence kidney-tonifying capsule | |
| CN1429596A (en) | Manufacturing process of Rujietai preparation | |
| CN1209139C (en) | Traditional Chinese medicine for curing vascular dementia and its preparing method | |
| CN1058882C (en) | Oral liquor for treating tumour and disease of liver, and preparation method thereof | |
| CN1291722C (en) | Use of oligoxylose in preparing medicine for treating diabetes | |
| CN100335111C (en) | Medicine for rheumatism and its preparation | |
| CN1231230C (en) | Apoplexy treating capsule and its preparation method | |
| CN1185964A (en) | Chinese medicine for cardio-cerebral blood vessel diseases | |
| CN117883507A (en) | Traditional Chinese medicine formula for indirectly reversing diabetes and preparation method thereof | |
| CN118178592A (en) | Traditional Chinese medicine composition for treating carotid plaque and preparation method and application thereof | |
| CN100333780C (en) | Chinese medicine for antisenility and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |